Arie Orenstein

Prof. Arie Orenstein is a prominent figure in Israeli medicine, known for his work in plastic surgery and advanced medical technologies.

Angel Investor Active Tel Aviv-Jaffa, Israel Est. 1997
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$1.5M
total disclosed, rounds participated
Stages

About

Prof. Arie Orenstein is a distinguished Israeli plastic surgeon and a key figure in the development of advanced medical technologies in Israel. He founded the Advanced Technologies Center at Sheba Medical Center in 1997, which fosters collaboration between clinicians, scientists, academics, and the medical technology industry. He also previously headed the Department of Plastic Surgery and the Laser Unit at Sheba Medical Center (formerly Tel ha-Shomer Hospital) from 1995 to 2011. He is also involved with "PROF. ARIE ORENSTEIN HOLDINGS LTD" in Tel Aviv-Jaffa.

Portfolio · 1

Investment activity

Portfolio by sector

Media & Entertainment Technologies1

Q&A

What is Arie Orenstein's primary investment focus by sector?
Arie Orenstein has invested in the Media & Entertainment Technologies sector, with Astral Vision as a notable portfolio company.
Can you name a key portfolio company for Arie Orenstein?
Arie Orenstein's portfolio includes Astral Vision, a B2B company founded in 2014 that develops virtual reality devices for thrill rides.
What is the typical funding stage for Arie Orenstein's investments?
Arie Orenstein has participated in Seed stage funding rounds, as seen with the investment in Astral Vision.
When did Arie Orenstein make their most recent recorded investment?
Arie Orenstein's most recent recorded investment was in October 2017.
What was the investment amount in Astral Vision?
Arie Orenstein participated in a funding round for Astral Vision that raised $1.5M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal namePROF. ARIE ORENSTEIN HOLDINGS LTD
Founded1997

Radar intelligence

Patents

EPO7